Paper · 4201751

Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.

Hansson L. Acta Med Scand Suppl, 1973. Cited by 78 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. Papers, record 4201751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4201751

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Beta-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity.; PubMed
Journal: Acta Med Scand Suppl; PubMed
Year: 1973; PubMed
Publication types: Clinical Trial, Controlled Clinical Trial, Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/4201751/; PubMed
The journal: https://conductscience.org/library/journal-index/0370331; PubMed
Citations, by iCite: 78; iCite
Relative citation ratio, by iCite: 4.6; iCite
Revised in PubMed: 2015-11-19; PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Hansson L	L

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Hemodynamics	Major topic
Hypertension	Major topic
Propranolol	Major topic
Renin	Major topic
Administration, Oral
Adult
Aged
Blood Pressure
Cardiac Output
Clinical Trials as Topic
Depression, Chemical
Heart Rate
Humans
Injections, Intravenous
Isoproterenol
Male
Middle Aged
Nitroglycerin
Placebos
Posture
Pressoreceptors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMID	Title	Journal	Year	In Papers	Source
7,428,794	Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients.	Eur J Clin Pharmacol	1980	https://conductscience.org/library/papers/7428794	PubMed
7,030,750	Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension.	Eur J Clin Pharmacol	1981	https://conductscience.org/library/papers/7030750	PubMed
6,753,891	Captopril and atenolol combined with hydrochlorothiazide in essential hypertension.	Br J Clin Pharmacol	1982	https://conductscience.org/library/papers/6753891	PubMed
6,125,175	How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.	Br J Clin Pharmacol	1982	https://conductscience.org/library/papers/6125175	PubMed
3,326,633	ISA--vasodilatation: improvement of organ perfusion.	Br J Clin Pharmacol	1987	https://conductscience.org/library/papers/3326633	PubMed
3,042,360	Drug treatment of hypertension.	Drugs	1988	https://conductscience.org/library/papers/3042360	PubMed
2,894,874	Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.	Br J Pharmacol	1988	https://conductscience.org/library/papers/2894874	PubMed
1,003,867	Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.	Klin Wochenschr	1976	https://conductscience.org/library/papers/1003867	PubMed
964,292	Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.	Eur J Clin Pharmacol	1976	https://conductscience.org/library/papers/964292	PubMed
957,599	Renin, aldosterone and arterial pressure responses to acute beta-adrenergic receptor blockage in hypertensive patients.	Klin Wochenschr	1976	https://conductscience.org/library/papers/957599	PubMed

1 to 10 of 23

See all 23 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
REN	5,972	PubTator's text mining	https://conductscience.org/library/genes/5972

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4201751

GET https://conductscience.org/api/papers/v1/4201751/cited_by?page=2

API reference For AI assistants